KHB Unveils Innovative Immunoassay Analyzer Polaris V150 at MEDICA 2025
Shanghai Kehua Bio-engineering Co., Ltd. (KHB), a leading global provider of in vitro diagnostic (IVD) solutions, is set to make waves at the MEDICA 2025 exhibition with the introduction of its newest product, the Polaris V150 chemiluminescent immunoassay analyzer. This compact platform is designed to meet the growing demands of small to medium-sized laboratories and facilitate urgent testing requirements in larger hospitals and outsourced laboratories.
Taking up only 0.36 square meters of space, the Polaris V150 achieves an impressive throughput of 150 tests per hour. This capability allows laboratories to maximize efficiency even in environments with spatial constraints. The analyzer supports continuous loading of samples, reagents, and reaction plates. Its STAT function prioritizes urgent specimens, ensuring quick clinical decision-making. The device accommodates 40 sample types and offers automated dilution, alongside a comprehensive detection of fluid levels, clots, and collision prevention measures, enhancing reliability in workflows.
Equipped with a cutting-edge ALP-AMPPD chemiluminescence system, the Polaris V150 guarantees high precision with a low coefficient of variation (CV < 3%) across all analyses. A universal reagent kit with QR code-enabled calibrators and reference curves standardizes operations and streamlines reagent management. The extensive and expanding test menu includes over 60 assays on 10 panels covering essential diagnostic needs, including thyroid function, sex hormones, tumor markers, infectious diseases, cardiac markers, inflammation, glycometabolism, anemia, bone metabolism, and more.
In addition to its analytical performance, the Polaris V150 incorporates intelligent systems that improve the laboratory experience. It offers real-time monitoring of reagent statuses and consumables, providing laboratories with comprehensive visibility into operational readiness. The clear, intuitive user interface and built-in touchscreen facilitate efficient navigation and optimized management while reducing training requirements and enhancing overall user convenience.
To ensure continuous high-quality performance, the analyzer features round-the-clock internal cooling (2–8 °C) for up to 12 reagent positions, maintaining optimal stability. Functions such as remote monitoring and automated maintenance minimize downtime and streamline maintenance workflows, helping labs achieve high operational continuity.
At MEDICA 2025, the Polaris V150 stands out at the KHB booth, capturing the attention of global partners in need of compact yet high-performance immunoassay solutions. Hands-on demonstrations and technical consultations provided by the KHB expert team grant visitors in-depth insights into the analyzer's capabilities and usability in both standard and emergency lab environments. "The interest we garnered at MEDICA highlights a strong demand for compact, high-quality chemiluminescent systems like the Polaris V150," stated a KHB product manager. "We are excited to share this innovation with our international partners and support laboratories worldwide with effective solutions for immunoassay testing."
Shanghai Kehua Bio-engineering Co., Ltd. (KHB) is publicly traded under the stock code 002022.SZ and specializes in in vitro diagnostics (IVD). With a comprehensive product lineup focused on immunodiagnostics, biochemical diagnostics, molecular diagnostics, and point-of-care testing (POCT), KHB has evolved since its establishment in 1981 into a high-tech enterprise integrating R&D, production, and marketing. The company was listed on the Shenzhen Stock Exchange in 2004. For more information, visit KHB's official website and their pages on LinkedIn, Facebook, and Twitter.
Compact Design with High Efficiency
Taking up only 0.36 square meters of space, the Polaris V150 achieves an impressive throughput of 150 tests per hour. This capability allows laboratories to maximize efficiency even in environments with spatial constraints. The analyzer supports continuous loading of samples, reagents, and reaction plates. Its STAT function prioritizes urgent specimens, ensuring quick clinical decision-making. The device accommodates 40 sample types and offers automated dilution, alongside a comprehensive detection of fluid levels, clots, and collision prevention measures, enhancing reliability in workflows.
Superior Accuracy via Innovative Technology
Equipped with a cutting-edge ALP-AMPPD chemiluminescence system, the Polaris V150 guarantees high precision with a low coefficient of variation (CV < 3%) across all analyses. A universal reagent kit with QR code-enabled calibrators and reference curves standardizes operations and streamlines reagent management. The extensive and expanding test menu includes over 60 assays on 10 panels covering essential diagnostic needs, including thyroid function, sex hormones, tumor markers, infectious diseases, cardiac markers, inflammation, glycometabolism, anemia, bone metabolism, and more.
Smart Features and User-Friendly Environment
In addition to its analytical performance, the Polaris V150 incorporates intelligent systems that improve the laboratory experience. It offers real-time monitoring of reagent statuses and consumables, providing laboratories with comprehensive visibility into operational readiness. The clear, intuitive user interface and built-in touchscreen facilitate efficient navigation and optimized management while reducing training requirements and enhancing overall user convenience.
Enhanced Reagent Stability and Smart Maintenance
To ensure continuous high-quality performance, the analyzer features round-the-clock internal cooling (2–8 °C) for up to 12 reagent positions, maintaining optimal stability. Functions such as remote monitoring and automated maintenance minimize downtime and streamline maintenance workflows, helping labs achieve high operational continuity.
Strong Showcasing at MEDICA 2025
At MEDICA 2025, the Polaris V150 stands out at the KHB booth, capturing the attention of global partners in need of compact yet high-performance immunoassay solutions. Hands-on demonstrations and technical consultations provided by the KHB expert team grant visitors in-depth insights into the analyzer's capabilities and usability in both standard and emergency lab environments. "The interest we garnered at MEDICA highlights a strong demand for compact, high-quality chemiluminescent systems like the Polaris V150," stated a KHB product manager. "We are excited to share this innovation with our international partners and support laboratories worldwide with effective solutions for immunoassay testing."
About KHB Group
Shanghai Kehua Bio-engineering Co., Ltd. (KHB) is publicly traded under the stock code 002022.SZ and specializes in in vitro diagnostics (IVD). With a comprehensive product lineup focused on immunodiagnostics, biochemical diagnostics, molecular diagnostics, and point-of-care testing (POCT), KHB has evolved since its establishment in 1981 into a high-tech enterprise integrating R&D, production, and marketing. The company was listed on the Shenzhen Stock Exchange in 2004. For more information, visit KHB's official website and their pages on LinkedIn, Facebook, and Twitter.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.